https://essa.comocreative.com/document/an-androgen-receptor-n-terminal-domain-antagonist-for-treating-prostate-cancer/ 2021-03-12T17:09:52+00:00 https://essa.comocreative.com/document/spongian-diterpenoids-inhibit-androgen-receptor-activity/ 2021-03-12T17:09:58+00:00 https://essa.comocreative.com/document/advances-in-small-molecule-inhibitors-of-androgen-receptor-for-the-treatment-of-advanced-prostate-cancer/ 2021-03-12T17:10:16+00:00 https://essa.comocreative.com/document/niphatenones-glycerol-ethers-from-the-sponge-niphates-digitalis-block-androgen-receptor-transcriptional-activity-in-prostate-cancer-cells-structure-elucidation-synthesis-and-biological-activity/ 2021-03-12T17:10:22+00:00 https://essa.comocreative.com/document/small-molecule-inhibitors-targeting-the-achilles-heel-of-androgen-receptor-activity/ 2021-03-12T17:10:32+00:00 https://essa.comocreative.com/document/regression-of-castrate-recurrent-prostate-cancer-by-a-small-molecule-inhibitor-of-the-amino-terminus-domain-of-the-androgen-receptor/ 2021-03-12T17:10:37+00:00 https://essa.comocreative.com/document/n-terminal-targeting-of-androgen-receptor-variant-enhances-response-of-castration-resistant-prostate-cancer-to-taxane-chemotherapy/ 2021-03-12T17:11:58+00:00 https://essa.comocreative.com/document/characterization-of-niphatenones-that-inhibit-androgen-receptor-n-terminal-domain/ 2021-03-12T17:12:22+00:00 https://essa.comocreative.com/document/a-phase-1-2-open-label-study-of-safety-and-antitumor-activity-of-epi-506-a-novel-ar-n-terminal-domain-inhibitor-in-men-with-metastatic-castration-resistant-prostate-cancer-mcrpc-with-progression-a/ 2021-03-12T17:14:20+00:00 https://essa.comocreative.com/document/co-targeting-androgen-receptor-splice-variants-and-mtor-signaling-pathway-for-the-treatment-of-castration-resistant-prostate-cancer/ 2021-03-12T17:15:30+00:00 https://essa.comocreative.com/document/targeting-androgen-receptor-activation-function-1-with-epi-to-overcome-resistance-mechanisms-in-castration-resistant-prostate-cancer/ 2021-03-12T17:16:34+00:00 https://essa.comocreative.com/document/analysis-of-ar-driven-resistance-mechanisms-in-a-phase-1-2-study-of-epi-506-a-novel-ar-n-terminal-domain-inhibitor-in-men-with-metastatic-castration-resistant-prostate-cancer-mcrpc-with-progressio/ 2021-03-12T17:22:37+00:00 https://essa.comocreative.com/document/preclinical-and-clinical-pharmacology-of-epi-7386-an-androgen-receptor-n-terminal-domain-inhibitor-for-castration-resistant-prostate-cancer/ 2021-03-12T17:23:30+00:00 https://essa.comocreative.com/document/epi-001-a-compound-active-against-castration-resistant-prostate-cancer-targets-transactivation-unit-5-of-the-androgen-receptor/ 2021-03-12T17:30:22+00:00 https://essa.comocreative.com/document/androgen-receptor-targeted-therapies-in-castration-resistant-prostate-cancer-bench-to-clinic/ 2021-03-12T17:31:08+00:00 https://essa.comocreative.com/document/an-imaging-agent-to-detect-androgen-receptor-and-its-active-splice-variants-in-prostate-cancer/ 2021-03-12T17:31:57+00:00 https://essa.comocreative.com/document/sintokamide-a-is-a-novel-antagonist-of-androgen-receptor-that-uniquely-binds-activation-function-1-in-its-amino-terminal-domain/ 2021-03-12T17:32:55+00:00 https://essa.comocreative.com/document/targeting-the-n-terminal-domain-of-the-androgen-receptor-a-new-approach-for-the-treatment-of-advanced-prostate-cancer/ 2021-03-12T17:33:46+00:00 https://essa.comocreative.com/document/efficacy-safety-tolerability-and-pharmacokinetics-of-epi-506-ralaniten-acetate-a-novel-androgen-receptor-ar-n-terminal-domain-ntd-inhibitor-in-men-with-metastatic-castration-resistant-prost/ 2021-03-12T17:36:57+00:00 https://essa.comocreative.com/document/lessons-learned-from-the-metastatic-castration-resistant-phase-1-of-epi-506-a-first-generation-androgen-receptor-n-terminal-domain-inhibitor/ 2021-03-12T17:39:14+00:00 https://essa.comocreative.com/document/next-generation-n-terminal-domain-androgen-receptor-inhibitor-with-improved-potency-and-metabolic-stability-in-castration-resistant-poster-cancers-models/ 2021-03-12T17:40:45+00:00 https://essa.comocreative.com/document/next-generation-n-terminal-domain-androgen-receptor-inhibitor-with-improved-potency-and-metabolic-stability-in-castration-resistant-poster-cancers-models-2/ 2021-03-12T17:41:59+00:00 https://essa.comocreative.com/document/next-generation-n-terminal-domain-androgen-receptor-inhibitor-with-improved-potency-and-metabolic-stability-in-castration-resistant-poster-cancers-models-3/ 2021-03-12T17:43:32+00:00 https://essa.comocreative.com/document/epi-7386-is-a-novel-n-terminal-domain-androgen-receptor-inhibitor-for-the-treatment-of-prostate-cancer/ 2021-03-12T17:45:03+00:00 https://essa.comocreative.com/document/treatment-of-castrated-resistant-prostate-cancer-with-epi-7386-a-second-generation-n-terminal-domain-androgen-receptor-inhibitor/ 2021-03-12T17:46:15+00:00 https://essa.comocreative.com/document/treatment-of-castrated-resistant-prostate-cancer-with-epi-7386-a-second-generation-n-terminal-domain-androgen-receptor-inhibitor-2/ 2021-03-12T17:47:25+00:00 https://essa.comocreative.com/document/ind-candidate-epi-7386-as-an-n-terminal-domain-androgen-receptor-inhibitor-in-development-for-the-treatment-of-prostate-cancer/ 2021-03-12T17:48:40+00:00 https://essa.comocreative.com/document/the-preclinical-characterization-and-development-of-epi-7386-an-n-terminal-domain-androgen-receptor-inhibitor-for-the-treatment-of-prostate-cancer/ 2021-03-12T17:50:13+00:00 https://essa.comocreative.com/document/pre-clinical-development-of-the-second-generation-n-terminal-domain-androgen-receptor-inhibitor-epi-7386-for-the-treatment-of-prostate-cancer/ 2021-03-12T17:51:25+00:00 https://essa.comocreative.com/document/pre-clinical-profile-of-epi-7386-a-second-generation-n-terminal-domain-androgen-receptor-inhibitor-for-the-treatment-of-prostate-cancer/ 2021-03-12T17:52:34+00:00 https://essa.comocreative.com/document/epi-7386-a-potent-n-terminal-domain-androgen-receptor-inhibitor-with-a-favorable-preclinical-safety-and-superior-in-vitro-in-vivo-profile-in-clinical-development-for-prostate-cancer/ 2021-03-12T17:53:32+00:00 https://essa.comocreative.com/document/the-preclinical-characterization-of-the-n-terminal-domain-androgen-receptor-inhibitor-epi-7386-for-the-treatment-of-prostate-cancer/ 2021-03-12T17:55:00+00:00 https://essa.comocreative.com/document/comprehensive-in-vitro-characterization-of-the-mechanism-of-action-of-epi-7386-an-androgen-receptor-n-terminal-inhibitor/ 2021-09-03T20:01:38+00:00 https://essa.comocreative.com/document/comprehensive-preclinical-characterization-of-the-mechanism-of-action-of-epi-7386-an-androgen-receptor-n-terminal-domain-inhibitor/ 2021-10-07T13:58:37+00:00 https://essa.comocreative.com/document/hong-nh-et-al-comprehensive-preclinical-characterization-of-the-mechanism-of-action-of-epi-7386-an-androgen-receptor-n-terminal-domain-inhibitor-2021-prostate-cancer-foundation-pcf-annual-scien/ 2021-10-28T21:26:03+00:00 https://essa.comocreative.com/document/hong-nh-et-al-androgen-receptor-ar-n-terminal-domain-degraders-can-degrade-ar-full-length-and-ar-splice-variants-in-crpc-preclinical-models-2022-american-association-for-cancer-research-aacr-a/ 2022-04-08T17:18:43+00:00 https://essa.comocreative.com/document/laccetti-a-et-al-oral-epi-7386-in-patients-with-metastatic-castration-resistant-prostate-cancer-results-from-the-first-in-human-dose-escalation-phase-1a-study-prostate-cancer-foundation-2022-scie/ 2022-10-26T11:54:56+00:00 https://essa.comocreative.com/document/laccetti-a-et-al-phase-1-2-study-of-epi-7386-in-combination-with-enzalutamide-enz-compared-with-enz-alone-in-subjects-with-metastatic-castration-resistant-prostate-cancer-mcrpc-preliminary-res/ 2022-10-26T11:55:54+00:00 https://essa.comocreative.com/document/hong-nh-et-al-advances-in-the-development-of-a-targeted-n-terminal-domain-androgen-receptor-degrader-anitac-for-the-treatment-of-prostate-cancer-prostate-cancer-foundation-2022-scientific-retrea/ 2022-10-26T14:00:31+00:00 https://essa.comocreative.com/document/hong-nh-et-al-advances-in-the-development-of-a-targeted-n-terminal-domain-androgen-receptor-degrader-anitac-for-the-treatment-of-prostate-cancer-34th-eortc-nci-aacr-symposium-on-molecular-target/ 2022-10-26T20:02:31+00:00 https://essa.comocreative.com/document/lacetti-andrew-et-al-phase-1-2-trial-of-oral-epi-7386-in-combination-with-enzalutamide-enz-compared-with-enz-alone-in-subjects-with-metastatic-castration-resistant-prostate-cancer-mcrpc-prelimi/ 2023-02-16T15:10:24+00:00 https://essa.comocreative.com/document/russel-pachynski-et-al-a-phase-1-trial-of-oral-epi-7386-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-update-from-the-first-in-human-study-2023-american-society-of-clini/ 2023-02-16T15:11:16+00:00